Concepedia

Neil Johnson

NJ

Statistics

Publications

33

Citations

3.5K

H-Index

25

Active since

1976

Affiliations

Fox Chase Cancer Center(Current)

Temple University

University of Washington

Brigham and Women's Hospital

Harvard University

Neil Johnson is an author at Fox Chase Cancer Center specializing in medicine, cell biology, and natural sciences.

ORCID

Top concepts

Publications per year

1976–2024

33

Publications

33

Combining PARP with ATR inhibition overcomes PARP inhibitor and platinum resistance in ovarian cancer models

Hyoung Kim, Haineng Xu, Erin George et al. · Nature Communications · 2020 · 349 citations · Full text

Compromised CDK1 activity sensitizes BRCA-proficient cancers to PARP inhibition

Neil Johnson, Yuchen Li, Zandra E. Walton et al. · Nature Medicine · 2011 · 301 citations

, , +5

Replication gaps are a key determinant of PARP inhibitor synthetic lethality with BRCA deficiency

Ke Cong, Min Peng, Arne Nedergaard Kousholt et al. · Molecular Cell · 2021 · 298 citations · Full text

, , +8

CDK12 Inhibition Reverses De Novo and Acquired PARP Inhibitor Resistance in BRCA Wild-Type and Mutated Models of Triple-Negative Breast Cancer

Shawn F. Johnson, Cristina Cruz, Ann Katrin Greifenberg et al. · Cell Reports · 2016 · 279 citations · Full text

Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinoma

Olga Kondrashova, Monique Topp, Ksenija Nesic et al. · Nature Communications · 2018 · 277 citations · Full text

Rows per page

1–5 of 33